The adipocytokine leptin centrally regulates body weight by enhancing metabolic rate and signaling satiety, but it also has wideranging peripheral effects. Leptin receptors are expressed on vascular smooth muscle cells and have a role in maintaining vascular tone. We investigated the vascular effects of leptin repletion or calorie restriction on leptin-deficient mice (ob/ob) and a leptin antagonist on wild-type (WT) mice. Aortic compliance was assessed by the measurement of pulse wave velocity by noninvasive Doppler; blood pressure was measured by left ventricular catheterization. We found that ob/ob mice have much stiffer aortas than WT mice and that reduction in aortic stiffness was greater in ob/ob mice treated with leptin vs calorie restriction, despite similar weight loss. Interestingly, treating WT mice with a leptin antagonist increases aortic stiffness with no change in weight. Thus, we conclude that leptin is essential for maintaining normal aortic compliance independent of body weight.
Introduction
The central vs peripheral roles of leptin have been intensely debated. Serum levels of this adipokine are proportional to fat mass, acting to suppress satiety through the hypothalamus and enhance overall metabolism by modulating energy expenditure. 1 Elevated circulating leptin is associated with vascular calcification, 2 increased blood pressure 3 and decreased vascular compliance; 4 however, these effects may be attributable to leptin resistance rather than leptin excess itself. 5 Conversely, leptin provides beneficial receptor-mediated effects on vascular tone and growth. Both long (Ob-Rb) and short (Ob-Ra) isoforms of leptin receptors are highly expressed in endothelial 6 and vascular smooth muscle cells, 7 with leptin stimulation enhancing nitric oxide production. Angiogenesis is accelerated with hyperleptinemia, 6 and improved endothelial function is evident in ex vivo experiments in ob/ob mice. 8 On the basis of potential vascular benefit of intact leptin signaling beyond its primary effect on body weight, we examined aortic compliance and blood pressure in lean and obese mice with disrupted leptin signaling.
Materials and methods

Animals
We studied five groups (n ¼ 5-9/group) of 7-to 9-month-old ob/ob and C57BL/6 (WT) mice (Jackson Laboratory, Bar Harbor, ME, USA): control (phosphate-buffered salineinfused) ob/ob (OB), leptin-treated ob/ob (0.3 mg/kg/day; Amgen, Thousand Oaks, CA, USA; OB-LT) and calorierestricted ob/ob (OB-CR), all treated for 4 weeks, and control (phosphate-buffered saline-infused) WT and leptin-antagonist-treated WT (leptin triple mutant L39A/D40A/F41A, 0.3 mg/kg/day; Protein Laboratories, Rehovot, Israel; WT-LA) treated for 2 weeks. Drugs were delivered through osmotic pumps (Alzet, Cupertino, CA, USA) as previously described. 8 OB-CR were calorie restricted to achieve weight loss similar to OB-LT. 8 A second set of animals (10-12 weeks old, n ¼ 5/group) were treated for 4 weeks for blood pressure and serum biomarker measurements.
Aortic stiffness
We assessed aortic stiffness by pulse wave velocity (PWV) using a Pulse Doppler Spectrum Analyzer (Indus Instruments, Houston, TX, USA). Animals were anesthetized using isoflurane (1-2%) and placed supine on a temperature-controlled board (THM100, Indus Instruments). Using an electrocardiogram-triggered 20 MHz probe (Indus Instruments), aortic flow at descending and abdominal aortic sites 4 cm apart was recorded. PWV was determined by dividing the separation distance of measurement points by the time taken to travel this distance as measured from R-peaks of the electrocardiogram. 9 Blood pressure Blood pressure was measured by left ventricular catheterization as previously described. 10 After isoflurane sedation, mice were anesthetized with an intraperitoneal injection of urethane (800 mg/kg), etomidate (5 mg/kg) and morphine (2 mg/kg), and were mechanically ventilated. The thoracic cavity was exposed and a pressure catheter (SPR-719, Millar Instruments; Houston, TX, USA) was inserted into the left ventricular apex and advanced retrograde into the ascending aorta.
Serum biomarkers
Animals were fasted for 12 h before blood was collected by cardiac puncture. Serum was separated by centrifuging samples at 12 000 g for 15 min. An aliquot was sent to 
Results
Aortic PWV was greater in ob/ob mice (5.14 ± 0.05 m/s) compared with WT (3.08±0.01 m/s; Po0.0001). Strikingly, leptin greatly reduced vascular stiffness in ob/ob mice (3.33 ± 0.03 m/s; Po0.0001 vs ob/ob). Although calorie restriction lowered PWV somewhat (4.15±0.03 m/s; Po0.0001 vs ob/ob), it remained significantly higher than OB-LT (Po0.0001; Figure 1a ) despite similar body weight (Figure 1b) . Consistent with our findings in ob/ob mice, WT-LA showed higher PWV (3.87±0.02 m/s; Po0.0001 vs WT) despite no change in body weight. These data suggest that leptin is important in maintaining normal vascular compliance independent of body weight. There were no differences in mean arterial blood pressure among all five groups (Figure 1c) , although ob/ob had slightly higher systolic blood pressure and unchanged diastolic pressure vs WT. Leptin repletion and calorie restriction both normalized systolic pressure in ob/ob. Thus, alterations in blood pressure do not account for the observed changes in vascular stiffness.
As leptin is known to regulate glucose and lipid metabolism, we examined serum metabolic markers to determine their relative impact on vascular compliance. Glucose levels decreased to WT levels in OB-LT and OB-CR, but increased in WT-LA (Figure 1d ). Insulin levels were unchanged in OB-CR when compared with OB, but decreased to near WT levels with leptin infusion (Figure 1e ). Total triglycerides (Figure 1f ) and cholesterol ( Figure 1g ) were reduced in OB-LT and OB-CR vs ob/ob and cholesterol was increased in WT-LA.
Discussion
This study sheds some light on the role of leptin in maintaining vascular compliance. We have established that disruption of leptin signaling, whether due to congenital leptin deficiency or pharmacologic antagonism, leads to compromised vascular compliance independent of body weight. Hyperglycemia, hyperinsulinemia and hyperlipidemia are all associated with increased vascular stiffness and are found in ob/ob mice. Leptin treatment ameliorated all these, whereas leptin antagonism in WT elevated serum glucose, cholesterol and triglycerides. Persistent insulin resistance has been reported in OB-CR, 11 consistent with our results. 12 It is possible that the protective action that leptin has on vascular compliance is because of a combination of insulin and cholesterol-related effects; however, other potential mechanisms include limiting ectopic lipid deposition and improving peripheral tissue sensitivity to insulin. 13 Further studies on the role of leptin in modulating endothelial function and nitric oxide bioavailability are necessary to elucidate the mechanism of vascular protection.
